http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2632102-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_859e9e735009138cdc05c7a45525de7d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
| filingDate | 2016-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6821c9cb7d0bfd5e5a99594d07127602 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b678918af23f5c4dbfe9f7ca716d246 |
| publicationDate | 2017-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2632102-C1 |
| titleOfInvention | Method for assessment of chronic generalized periodontitis treatment effectiveness |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to the study of the physical and chemical properties of a biological fluid, and can be used in therapeutic dentistry to evaluate the effectiveness of treatment of chronic generalized periodontitis (CHG) in patients with metabolic syndrome (MS). The method includes a biochemical analysis of oral fluid before and after treatment in patients with diagnosed chronic generalized periodontitis and diagnosed metabolic syndrome, using a spectrophotometric assay, the lipid profile of the oral fluid is determined, namely the concentration of triglycerides (TG), total cholesterol (TC), low density lipoprotein (LDL) and high-density lipoprotein (HDL). When TG concentration changes from 0.04±0.01 mmol/l to 0.01±0.001 mmol/l, TC changes from 0.08±0.02 mmol/l to 0.04±0.02 mmol/l, LDL changes from 0.04±0.001 mmol/l to 0.01±0.001 mmol/l, HDL changes from 0.08±0.01 mmol/l to 0.12±0.01 mmol/l, treatment is evaluated as effective. Significant changes in the lipid profile in the oral fluid of patients with generalized periodontitis (P<0.01) suggest that for the evaluation of the HCV treatment effectiveness, saliva study is indicative and can be recommended for use under the conditions of periodontics department. n EFFECT: improved assessment accuracy. n 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2714506-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2745698-C1 |
| priorityDate | 2016-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 170.